Aroa Biosurgery Limited

A$0.53As of Sun 8 Nov 2026, 12:00 UTC
ASX:ARXHealthcare
Country Australia
PE (Fwd) •••
TSR 6Y CAGR (15.10%)
Div yield —
ROE 4.86%
Medical Devices
Beta (5Y) 0.87
PE TTM 49.35
TSR TTM (31.61%)
Mkt cap A$183.3M
ROIC 6.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.638
20.33%
(72.52%)
Hold 4|5|12|9|0
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.01
0.01
0.01
0.01
0.34%
(6.43%)
4.31%
16.55%
Revenue$M
8.073
7.951
7.947
8.122
6.65%
2.34%
0.91%
1.13%
Peers (US$125.9M)
Cap (US$)
PE
152.0M
13.45x
65.26M
12.46x
128.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.910
(0.273)
(0.266)
EBIT/Intx
0.746
0.449
0.400
Own earn%
153.18
59.02
49.20
Sh yield%
37.92
46.30
39.70
Owners
Insiders/Inst%
1.36
43.74
Short interest%
0.81
SBC / revenue%
4.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
12–18
$1 testx
0.0
Incr. ROIC%
7